When it comes to convincing an audience of a particular viewpoint, you should lead with your best argument. A good song, at its core, is a good song. A terrible composition, however, will be rather obvious, even layered under mountains of reverb and autotune. And that’s the proposition behind Boston Scientific (BSX). For the time being, BSX stock is playing a catchy tune.
Specifically, I’m going to present a single argument: BSX stock is currently trading inside the market equivalent of a hot deck. As a card-counting blackjack player, it’s a relatively ideal time to take a shot. No, a probabilistic approach doesn’t guarantee success; after all, we’re still talking about what is probable, not what is certain.
